New Insights Into the Comorbidity Between ADHD and Major Depression in Adolescent and Young Adult Females

 This article was reviewed under and accepted by F. Xavier Castellanos, M.D., ad hoc Action Editor.This work was supported in part by a grant from USPHS (National Institute of Child Health and Human Development) 5R01 HD-36317-07 (J.B.), grant 1-R03-MH079954-01 from the National Institute of Mental Health (J.B.), and a grant from the Lilly Foundation (J.B.).This article is the subject of an editorial by Dr. Stephen P. Hinshaw in this issue.Disclosure: Dr. Biederman receives research support from, has been a speaker for, or is on the advisory boards of Shire, Eli Lilly, Pfizer, McNeil, Abbott, Bristol-Myers Squibb, New River Pharmaceuticals, Cephalon, Janssen, Novartis, UCB Pharma, AstraZeneca, Forest Laboratories, GlaxoSmithKline, Stanley Medical Institute, Lilly Foundation, Prechter Foundation, National Institute of Mental Health, National Institute of Child Health and Human Development, National Institute of Drug Abuse, and Neurosearch. Dr. Mick receives grant support from McNeil Pediatrics and Janssen Pharmaceuticals. Dr. Spencer receives research support from, is a speaker for, or is on the advisory boards of Shire Laboratories, Eli Lilly, GlaxoSmithKline, Pfizer, McNeil Pharmaceutical, Novartis, National Institute of Mental Health, and Wyeth-Ayerst. Dr. Faraone receives research support from, is a speaker for, or is on the advisory boards of Eli Lilly, McNeil Consumer & Specialty Pharmaceuticals, Shire, Noven Pharmaceuticals, Cephalon, National Institute of Mental Health, National Institute of Child Health and Human Development, and National Institute of Neurological Disorders and Stroke. The other authors report no conflicts of interest.

PII: S0890-8567(09)62398-4

doi: 10.1097/CHI.0b013e31816429d3

© 2008 The American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc. All rights reserved.